Christopher Kim - Chairman and CMO, Director at Apimeds Pharmaceuticals US, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman and CMO, Director
Stock Symbol
APUS on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Kim since 10/11/2024

Holdings reported by Christopher Kim for Apimeds Pharmaceuticals US, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.01 per share 278K $486K $1.75 May 16, 2025 Direct

Transactions reported by Christopher Kim for Apimeds Pharmaceuticals US, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.